Haemostatic Properties of Chrysophyllum Caïnito L. (Sapotaceae) in Wistar Rat
Keywords:
time of bleeding, rate of blood plates, hemoglobin, hematocrit.Abstract
The measure of certain blood parameters makes it possible to detect certain pathologies such as the hemophilia and leukemia among patients. Indeed, the aggregating and antiaggreganting activity of certain substances are known. It is a question in this work of checking the effect of the aqueous extract of Chrysophyllum cainito (AECc) on blood. It is a comparative study between AECc and two products of synthesis known for purpose which are the dicynone and the aspirin in vivo in the rats wistar specie Rattus norvegicus. The time of bleeding (TB), the number of blood plates, the red blood corpuscle rate, of hemoglobin, the hematocrit and the sedimentation test (TS) were evaluated. During the first week, the evolution of the time of bleeding (TB) is not significant for all the animals. The second week and until the end of the treatment, the TB drops for the animals treated with EACc in an amount-dependant way. Thus the fall is of 4% for the amounts of 300 mg/kg b.w, 17.4% for the amounts of 500 mg/kg b.w and 30.43% for the amounts of 1000 mg/kg b.w at the end of the treatment. In the animals treated with the dicynone, the fall reaches 41.55% at the end of the thirty days of treatment. On the other hand, in the rats treated with the aspirin, the TB increases as from the second week and reached the rise of 17.40% at the end of the thirty days. On the blood plates, AECc varies their number of manner proportions dependant as of the first week on treatment. The number of blood plates increases by 07.69% and 15.38% for the amount of AECc of 300 mg/kg b.w, 15th and 30th day. The amount of 500 mg/kg b.w of AECc makes increase the number of plates of 09.89%, 21.97%, and 25.16%, respectively 5th, 15th and 30th day.
The concentration of AECc of 1000 mg/kg b.w involves an increase in the plates of 22.31%, 27.36% and 33.07%, respectively with 5th, 15th and 30th day of treatment. The dicynone is managed with the rats with the amount of 500 mg/kg b.w the number of blood plates passes thus from 910±85.83 to 915±88.0, 918±87.0 then 920±92.0; 5th, 15th and 30th days of treatment is 0.55%, 0.88% and 1.09%. This variation is nonsignificant. On the other hand the aspirin managed with the rats with the amount of 500 mg/kg b.w cause a drop in the number of blood plates as of the 5th days with 900±88.2 then with 889±82.2 15th and 750±80.6 the 30th. These drops successive represent rates by -1%,-2.30% and -17.58%. The other factors such as the number of red blood corpuscles the rate of hemoglobin, the hematocrit and also the sedimentation test do not vary significantly before and during the treatment.
References
[2] V. Le Bellec and F. Le Bellec. Antilles Lesser trees. Vol. 2. PLB Editions. 128p. 2010
[3] K. N’guessan ; K.E. Amoikon ; M.S. Tiebre ; B. Kadja ; G.N. Zihiri. Effet de l’extrait aqueux des feuilles de Chrosophyllum cainito sur la glycémie des lapins diabétiques. Rev. Afri. de pharmacie et pharmacologie. 3(10) : pp 501-506. 2009
[4] WHO. Maternal mortality in 2005: WHO UNICEF, UNFPA and BM estimate. 20 Appia avenue, 1211 Genève 27 (Suisse). Pp 16-22. 2007
[5] UNICEF. Maternal and newborn health. The situation of children in the world.Newyork. ( 7-8) p 168. 2009
[6] J.C. K. Abo., K. L. Kouakou; A. Yapo. Hypotensive and antihypertensive affects of total aqueous extract of Justicia secunda Valm M. (Acanthaceae) in Rabbits. Intern. Journal of Sciences and Research vol. 5 (5): pp 1455-62. 2016
[7] S.C. Akomas and S.N. Ijioma. Bleeding and clothing time effect of ethanolic extracts of Chromolaena odorata versus Ocimum gratissimum treated albino rats. Journals of Medical Sciences. Vol. 2(1): pp 9-13. 2014
[8] Y.L. Chee; M. Greaves. Role of coagulation testing in predicting bleeding risk. Hematol. Journal. 4(6) : pp 373-8. 2003
[9] J.J. Schulte; J. Osborne; J.W. Benson; R. Cooke; M. Drayton; J. Murphy; J. Rennie; B. Speidel. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 90 (1): pp 31–35. 2005
[10] L. Kovács; G. Falkay. Etamsylate as inhibitor of prostaglandin biosynthesis in pregnant human myometrium in vitro. Experientia 37 (11): pp 1182–1183. 1981
[11] Martindale. The Complete Drug Reference, 36th edition, p-1065 Drug-Etamsylate: 3712p. Pharmaceutical Press. ISBN-13: 978-0853698425. 2009
[12] R.W. Hunt. Etamsylate for prevention of periventricular haemorrhage. Archives of Disease in Childhood: Fetal and Neonatal Edition 90 (1): pp 3–5. 2005
[13] L.D. Casa; D.H. Deaton; D.N. Ku. Role of high shear rate in thrombosis. J. Vasc. Surg. 61(4): pp 1068-80. 2015
[14] E.L. Grove. Antiplatelet effect of aspirin in patients with coronary artery disease. Dan. Med J. 59(9): B4506. 2012
[15] M. Würtz. Aspirin in coronary artery disease: an appraisal of functions and limitations. Dan Med J. 62(4):B5011. 2015
[16] C.D. Eichinger; A.L. Fogelson ; V. Hlady . Functional assay of antiplatelet drugs based on margination of platelets in flowing blood. Biointerphases. 11(2):029805. doi: 10.1116/1.4945305;.30 jun. 2016.
[17]Nomura S, Niki M, Nisizawa T, Tamaki T, Shimizu M. Microparticles as Biomarkers of Blood Coagulation in Cancer. Biomark Cancer. 1(7): pp 51-6. 2015
[18] E. Campello ; L. Spiezia ; C.M. Radu ; C. Bulato ; M. Castelli ; S. Gavasso ; P. Simioni. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.ThrombRes. 127(5): pp 473-7. 2011
[19] K.B. Neeves ; A.A. Onasoga ; R.R. Hansen ; J.J. Lilly ; D. Venckunaite ; M.B. Sumner , A.T. Irish ; G. Brodsky ; M.J. Manco-Johnson ; J.A. Di Paola. Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays. PLoS One.; 8(1):e54680. doi: 10.1371/journal.pone.0054680. Epub 23 jan. 2013.
[20] Stephens G, He M, Wong C, Jurek M, Luedemann HC, Shapurian G, Munnelly K, Muir C, Conley PB, Phillips DR, Andre P. Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs. Thromb J. 1;10(1): p 11. 2012
[21] J.I. Elizalde , J. Clemente ; J.L. Marín ; J. Panés ; B. Aragón ; A. Mas ; J.M. Piqué ; J. Terés . Early changes in hemoglobin and hematocritlevels after packed red cell transfusion in patients with acute anemia. Transfusion 37(6): pp 573-6. 1997
[22] C.H. Weng; J.B. Chen; J. Wang; C.C. Wu; Y. Yu; T.H. Lin. "Surgically Curable Non-Iron Deficiency Microcytic Anemia: Castleman's Disease.".Onkologie 34 (8-9): pp 456–8. 2011
[23] R. Zarychanski, D.S. Houston. "Anemia of chronic disease -- a harmful disorder, or a beneficial, adaptive response?"Can. Med. Assoc. J. 179 (4): pp 333–7. 2008
[24]K. N’guessan, K. Beugre, N.Z. Guede, T. Dossahoua, L. Ake-Assi. Screening phytochimique de quelques plantes médicinales ivoiriennes utilisées en pays Krobou (Agboville, Côte-d’Ivoire). Sciences et Nature, Vol. 6(1) : pp 1-15. 2009
[25] A. Bouquet and M. Debray. Plantes médicinales de Côte d’Ivoire. Imprimerie Louis Jean, Paris (France). 232p. 1974
[26] O.G. Nacoulma. Plantes médicinales et pratiques médicales traditionnelles au Burkina Faso: cas du plateau central. Thèse d’état, Université de Ouagadougou, 1996; 574p. 1996
[27] P. Jairj, Y. Wongkrajang, S. Thongpraditchote, P. Peungvicha, N. Bunyapraphatsara, N. Opartkiattikul. Guava leaf extract and topical haemostasis. Phytother. Res. 14 : pp 388-391. 2000
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.